Zimbabwe has rejected a substantial American healthcare agreement valued at 367 million US dollars (272 million pounds) spanning five years due to Washington's request for sensitive information.
The decision came to light following a government memo dated December was leaked, indicating that Head of State Emmerson Mnangagwa deemed the agreement was "skewed".
A government spokesperson later stated that the US was seeking health data for scientific study and commercial gain but was unwilling to share the benefits from any future treatments.
"We will now turn to the difficult and regrettable process of scaling back our support in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the US had donated over $1.9bn as health assistance to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has called for continued negotiations to find a agreement suitable to all parties so the nation's critical HIV treatment initiative can be sustained.
Broader Implications
This development follows a similar case in Kenya, where a high court suspended a similar health funding agreement after legal challenges were raised about the security of citizens' health data.
After resuming the presidency last year, US President Donald Trump has drastically cut overseas assistance and closed the key foreign aid agency.
USAID had managed aid for the US government, but Trump stated its expenditure was "inefficient" and his administration was seeking direct bilateral agreements to boost openness and responsibility.
According to reports, Sixteen nations in Africa have to date agreed to similar agreements, constituting more than $18.3bn of fresh investment.
Details of the Declined Deal
The money for Zimbabwe was intended to supported "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"It is our view this cooperation would have delivered immense benefits for Zimbabwean communities, particularly the 1.2 million men, women and children currently on antiretroviral therapy via US-supported programmes," Tremont commented.
However, government spokesperson Nick Mangwana said the proposed deal was "unfair".
"Our nation was requested to surrender its genetic material and health information for a long time, without any equivalent assurance of access to any medical innovations – such as new medicines or tests – that might be developed from that provided information," he stated.
"Put simply, our nation would provide the basic resources for medical research without any certainty that the end products would be available to our people if a future disease outbreak arise."
Sovereignty and International Frameworks
Mangwana further pointed out that the American exit from the World Health Organization (WHO) and its push of one-on-one health agreements were upending structures previously set up via the international health agency.
The spokesperson cited its Pandemic Benefit-Sharing system designed to deal with future pandemics.
"This framework is intended to guarantee that when a nation provides its samples, the resulting advantages – such as vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the capability to create them."
The government's concerns regarding the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.
"We welcome continued dialogue with our US partners on how future collaboration could be structured in a way that honours the sovereignty and interests of both nations."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it acknowledged the official position, but urged that talks must proceed considering much of the nation's HIV programmes depended on external financing.
"If specific concerns exist, such as those involving data governance or agreement terms, these can frequently be resolved via technical clarification and negotiated safeguards," the group added.
This impasse highlights the continuing tensions between receiving crucial foreign assistance and safeguarding a country's data in an ever more interconnected world.